These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2019666)

  • 1. Lack of effect of a high-fat meal on the volume of distribution of theophylline in humans.
    Parish RC; Wade WE; Middendorf WF
    J Clin Pharmacol; 1991 Mar; 31(3):248-52. PubMed ID: 2019666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of food-induced changes in the absorption of theophylline from Uniphyl tablets.
    Arkinstall WW; Hopkinson M; Rivington RN; Calcutt L; Aitken T; Stewart JH
    J Allergy Clin Immunol; 1988 Aug; 82(2):155-64. PubMed ID: 3273483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of theophylline elimination by diltiazem therapy.
    Nafziger AN; May JJ; Bertino JS
    J Clin Pharmacol; 1987 Nov; 27(11):862-5. PubMed ID: 3429693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the effect of food on the absorption of theophylline.
    Su YM; Cheng TP; Wen CY
    J Chin Med Assoc; 2003 Dec; 66(12):715-21. PubMed ID: 15015820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of different kinds of foods on the bioavailability of a sustained-release theophylline tablet.
    Gai MN; Thielemann AM; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):547-52. PubMed ID: 8294167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between rate and extent of absorption of oral theophylline from Uniphyl brand of slow-release theophylline and resulting serum concentrations during multiple dosing.
    Milavetz G; Vaughan LM; Weinberger MM; Harris JB; Mullenix TA
    J Allergy Clin Immunol; 1987 Nov; 80(5):723-9. PubMed ID: 3680816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food-induced changes in theophylline absorption from controlled-release formulations. Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption.
    Karim A; Burns T; Janky D; Hurwitz A
    Clin Pharmacol Ther; 1985 Dec; 38(6):642-7. PubMed ID: 4064466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hyperlipidic food on the kinetics of slow-release formulations of theophylline.
    Brazier JL; Benchekroun Y; Gillet A; Andre C
    Eur J Clin Pharmacol; 1989; 37(1):85-90. PubMed ID: 2591470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of food on the absorption of controlled-release theophylline in mini-swine.
    Shiu GK; Sager AO; Velagapudi RB; Prasad VK; Skelly JP
    Pharm Res; 1988 Jan; 5(1):48-52. PubMed ID: 3244609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food.
    Harrison LI; Mitra AK; Kehe CR; Klinger NM; Wick KA; McCarville SE; Cooper KM; Chang SF; Roddy PJ; Berge SM
    J Pharm Sci; 1993 Jun; 82(6):644-8. PubMed ID: 8331541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline: pharmacokinetics, metabolism and urinary excretion in dogs].
    Kuze T; Miyazaki H; Taneike T
    Nihon Yakurigaku Zasshi; 1988 May; 91(5):325-34. PubMed ID: 3410380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of atropine on pharmacokinetics of theophylline in rabbits.
    Li JH; Yang SM; Deng ZH
    Drug Metabol Drug Interact; 1991; 9(2):115-22. PubMed ID: 1800018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH; Sollie FA; Sauter R; Steinijans VW
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of macrocomponents of food on the pharmacokinetics of a long acting preparation of anhydrous theophylline.
    Sangeeta ; Raina RK; Bano G
    Indian J Physiol Pharmacol; 1993 Oct; 37(4):303-7. PubMed ID: 8112806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.